NO301651B1 - Approach. for the protection of a fat, food, cosmetic or pharmaceutical product content. a fatty substance against oxidation, fat, cosmetic, animal fat and vegetable oil, and of coenzyme Q as an antioxidant - Google Patents
Approach. for the protection of a fat, food, cosmetic or pharmaceutical product content. a fatty substance against oxidation, fat, cosmetic, animal fat and vegetable oil, and of coenzyme Q as an antioxidant Download PDFInfo
- Publication number
- NO301651B1 NO301651B1 NO904647A NO904647A NO301651B1 NO 301651 B1 NO301651 B1 NO 301651B1 NO 904647 A NO904647 A NO 904647A NO 904647 A NO904647 A NO 904647A NO 301651 B1 NO301651 B1 NO 301651B1
- Authority
- NO
- Norway
- Prior art keywords
- cosmetic
- fat
- fatty substance
- coenzyme
- pharmaceutical product
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims abstract description 32
- 239000002537 cosmetic Substances 0.000 title claims abstract description 24
- 235000017471 coenzyme Q10 Nutrition 0.000 title claims abstract description 23
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title claims abstract description 23
- 230000003647 oxidation Effects 0.000 title claims abstract description 21
- 238000007254 oxidation reaction Methods 0.000 title claims abstract description 21
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract description 20
- 229940127557 pharmaceutical product Drugs 0.000 title claims abstract description 20
- 235000013305 food Nutrition 0.000 title claims abstract description 7
- 235000019197 fats Nutrition 0.000 title claims description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims description 6
- 239000008158 vegetable oil Substances 0.000 title claims description 6
- 235000019737 Animal fat Nutrition 0.000 title claims description 4
- 230000003078 antioxidant effect Effects 0.000 title description 7
- 239000003963 antioxidant agent Substances 0.000 title description 6
- 235000006708 antioxidants Nutrition 0.000 title description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 29
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 14
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 14
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 14
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 13
- 239000003921 oil Substances 0.000 claims description 9
- 235000019198 oils Nutrition 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000010473 blackcurrant seed oil Substances 0.000 claims description 5
- 239000005515 coenzyme Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract description 3
- 235000010445 lecithin Nutrition 0.000 description 11
- 239000000787 lecithin Substances 0.000 description 11
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 9
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 8
- 235000021323 fish oil Nutrition 0.000 description 7
- 229940067606 lecithin Drugs 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 229940035936 ubiquinone Drugs 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000004059 quinone derivatives Chemical class 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 125000004151 quinonyl group Chemical group 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000005028 tinplate Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3571—Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0092—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Abstract
Description
Foreliggende oppfinnelse vedrører en fremgangsmåte for beskyttelse av et fettstoff eller et næringsmiddel, kosmetisk eller farmasøytisk produkt inneholdende et fettstoff mot oksydasjon og anvendelse av koenzym Q som et antioksiderings-middel i et næringsmiddel, kosmetisk eller farmasøytisk produkt inneholdende et fettstoff, fettstoff eller kosmetisk produkt; dyrefettstoff, spesielt olje fra marine dyr; vegetabilsk olje, spesielt solbærfrøolje. The present invention relates to a method for protecting a fatty substance or a foodstuff, cosmetic or pharmaceutical product containing a fatty substance against oxidation and the use of coenzyme Q as an antioxidant in a foodstuff, cosmetic or pharmaceutical product containing a fatty substance, fatty substance or cosmetic product; animal fat, especially oil from marine animals; vegetable oil, especially blackcurrant seed oil.
Det er kjent at koenzym Q (CoQ), eller ubiquinon som er blitt isloert fra lipidene i mitokondriene, er involvert i hovedmekanismen for energiproduksjon ved respirasjon, ved transport av elektroner i mitokondriene og i oksidativ fosforylering. Dennes antioksideringsmiddelaktivitet i biologiske media er kjent, jfr. for eksempel Littarru et al., Fats and Perspectives, Drugs exptl. clin. Res. X (7), 491-496. I et annet miljø, så som et næringsmiddel, kosmetisk eller farmasøytisk produkt inneholdende lipider, vil den oksiderte formen, dvs. quinon, være ventet å ikke ha noen antioksyderingsmiddelaktivitet på grunn av at quinoner normalt er betraktet å være deaktiveringsprodukter til antioksideringsmidler av hydroquinontype. It is known that coenzyme Q (CoQ), or ubiquinone which has been isolated from the lipids in the mitochondria, is involved in the main mechanism of energy production during respiration, in the transport of electrons in the mitochondria and in oxidative phosphorylation. Its antioxidant activity in biological media is known, cf. for example, Littarru et al., Fats and Perspectives, Drugs exptl. clin. Res. X (7), 491-496. In another environment, such as a food, cosmetic or pharmaceutical product containing lipids, the oxidized form, i.e. quinone, would be expected to have no antioxidant activity because quinones are normally considered to be deactivation products of hydroquinone-type antioxidants.
Det er nå uventet oppdaget at ubiquinon og dennes quinonform har en betraktelig antioksyderingsmiddelaktivitet i næringsmiddel, kosmetisk eller farmasøytiske produkter inneholdende lipider, spesielt i oljer som er rike på polyumettede fettsyrer. It has now been unexpectedly discovered that ubiquinone and its quinone form have considerable antioxidant activity in food, cosmetic or pharmaceutical products containing lipids, especially in oils rich in polyunsaturated fatty acids.
Foreliggende oppfinnelse vedrører følgelig en fremgangsmåte for beskyttelse av et fettstoff, et næringsmiddel, kosmetisk eller farmasøytisk produkt inneholdende et fettstoff mot oksidasjon, kjennetegnet ved at koenzym Q inkorporeres i fettstoffet eller i næringsmidlet, det kosmetiske eller farmasøytiske produkt i en mengde på 0,1 til 5 vekt-56, basert på vekten til fettstoffet. The present invention therefore relates to a method for protecting a fatty substance, a foodstuff, cosmetic or pharmaceutical product containing a fatty substance against oxidation, characterized in that coenzyme Q is incorporated into the fatty substance or into the foodstuff, the cosmetic or pharmaceutical product in an amount of 0.1 to 5 weight-56, based on the weight of the fat.
Oppfinnelsen vedrører også fettstoff eller kosmetisk produkt; dyrefettstoff, spesielt olje fra marine dyr; vegetabilsk olje, spesielt solbærfrøolje som er kjennetegnet ved at de er beskyttet mot oksidasjon ved anvendelse av fremgangsmåten ifølge kravene. The invention also relates to fatty substance or cosmetic product; animal fat, especially oil from marine animals; vegetable oil, in particular blackcurrant seed oil which is characterized in that it is protected against oxidation using the method according to the claims.
Det er også beskrevet anvendelse av koenzym 0 i et næringsmiddel, kosmetisk eller farmasøytisk produkt inneholdende et fettstoff for å beskytte det mot oksidasjon i en mengde på 0,1 til 5 vekt-#, basert på vekten til fettstoffet. It is also described the use of coenzyme 0 in a foodstuff, cosmetic or pharmaceutical product containing a fatty substance to protect it from oxidation in an amount of 0.1 to 5 wt-#, based on the weight of the fatty substance.
Det er videre beskrevet anvendelse av koenzym Q i kombinasjon med askorbinsyre og et naturlig emulgeringsmiddel i et næringsmiddel, kosmetisk eller farmasøytisk produkt for å beskytte det mot oksidasjon i en mengde på 0,1 til 5 vekt-56 basert på vekten til fettstoffet. It is further described the use of coenzyme Q in combination with ascorbic acid and a natural emulsifier in a food, cosmetic or pharmaceutical product to protect it against oxidation in an amount of 0.1 to 5 weight-56 based on the weight of the fatty substance.
I foreliggende oppfinnelse skal betegnelsen "næringsmiddel-produkt" forståes i vid forstand omfattende produkter ment for humant eller dyrefordøyelse, forutsatt at de inneholder lipider mottagelig for oksydasjon. Likeledes skal et kosmetisk eller farmasøytisk produkt forstås i vid forstand antatt for topisk applikasjon eller for oral, enteral eller parenteral administrajson forutsatt at produktet det gjelder inneholder lipider mottagelige for oksydasjon. In the present invention, the term "food product" is to be understood in a broad sense to include products intended for human or animal digestion, provided they contain lipids susceptible to oxidation. Likewise, a cosmetic or pharmaceutical product is to be understood in the broadest sense assumed for topical application or for oral, enteral or parenteral administration provided that the product in question contains lipids susceptible to oxidation.
Ifølge oppfinnelsen skal CoQ forstås som et quinonderivat tilsvarende følgende formel der n = 6-10. Forbindelsen CoQ^o»der n = 10, er foretrukket på grunn av at den er den mest vanlige og for tiden er det eneste industrielt tilgjengelige derivatet. According to the invention, CoQ is to be understood as a quinone derivative corresponding to the following formula where n = 6-10. The compound CoQ^o» where n = 10 is preferred because it is the most common and is currently the only industrially available derivative.
I fremgangsmåten eller ved anvendelsen ifølge foreliggende oppfinnelse, er CoQ inkorporert i væskefasen til legemidlet, det kosmetiske eller farmasøytiske produktet i en mengde på 0,1 til 5 vekt-# basert på lipidene tilstede i produktet. Dersom mindre enn 0, 1% blir tilsatt eller anvendt, er det en fare for at lipidene i produktet det gjelder kanskje ikke er tilstrekkelig beksyttet. Dersom mer enn 556 blir tilsatt eller anvendt, er beskyttelsesnivået som blir oppnådd ikke særlig høyere enn det som kan bli tilveiebragt ved tilsetning av mengder i det angitte området. In the method or application according to the present invention, CoQ is incorporated into the liquid phase of the drug, cosmetic or pharmaceutical product in an amount of 0.1 to 5 wt-# based on the lipids present in the product. If less than 0.1% is added or used, there is a risk that the lipids in the product in question may not be sufficiently protected. If more than 556 is added or used, the level of protection achieved is not significantly higher than that which can be provided by adding amounts in the range indicated.
I en foretrukket utførelsesform ifølge fremgangsmåten i oppfinnelsen blir CoQ, som er lipooppløselig, anvendt sammenblandet med andre antioksideringsmidler som har evne til å produsere en synergistisk virkning, for eksempel vannoppløselig askorbinsyre (AA), i nærvær av et naturlig emulgeringsmiddel. In a preferred embodiment according to the method in the invention, CoQ, which is liposoluble, is used in combination with other antioxidants that have the ability to produce a synergistic effect, for example water-soluble ascorbic acid (AA), in the presence of a natural emulsifier.
I foreliggende oppfinnelse skal et "naturlig emulgeringsmiddel" bety hvilke som helst av de naturlig forekommende ikke-ioniske overflateaktive midlene, for eksempel saponiner eller ioniske overflateaktive midler, for eksempel fos-folipider av dyre- eller grønnsaksopprinnelse fra melk, egg eller soya, fortrinnsvis lecitiner, for eksempel kommersielle lecitiner, rensede lecitiner, soyalecitinfraksjoner. Naturen til emulgeringsmidlet som blir anvendt har bare en sekundær virkning på virkningen observert, forutsatt at det har evne til å danne en stabil dispersjon av AA i et vannfritt produkt, for eksempel et fettstoff eller et næringsmiddel inneholdende et fettstoff eller et kosmetisk eller farmasøy-tisk produkt inneholdende et fettstoff. Det er foretrukket å anvende soyalecitiner eller fraksjoner derav som er meget forekommende og økonomisk. In the present invention, a "natural emulsifier" shall mean any of the naturally occurring non-ionic surfactants, for example saponins or ionic surfactants, for example phospholipids of animal or vegetable origin from milk, eggs or soy, preferably lecithins , for example commercial lecithins, purified lecithins, soy lecithin fractions. The nature of the emulsifier used has only a secondary effect on the effect observed, provided that it has the ability to form a stable dispersion of AA in an anhydrous product, for example a fatty substance or a foodstuff containing a fatty substance or a cosmetic or pharmaceutical product containing a fatty substance. It is preferred to use soy lecithins or fractions thereof, which are widely available and economical.
Den foretrukne antioksyderingsmiddelblandingen egnet for anvendelse i henhold til oppfinnelsen, inneholder fortrinnsvis 2,5 til 10#, og fortrinnsvis rundt 5% CoQ og 2,5 til 205É og fortrinnsvis 5 til 20% AA, basert på vekten til naturlig emulgeringsmiddel. The preferred antioxidant composition suitable for use in accordance with the invention preferably contains 2.5 to 10#, and preferably about 5% CoQ and 2.5 to 205É and preferably 5 to 20% AA, based on the weight of natural emulsifier.
Det er selvfølgelig mulig å anvende blandingen som den er, eller å inkorporere de forskjellige komponentene av blandingen separat fra fettstoffet som skal bli beskyttet. I det tilfelle hvor for eksempel fettstoffet er en vegetabilsk olje som allerede naturlig inneholder lecitin (LC), for eksempel soyabønneolje, er det tilstrekkelig å tilsette CoQ og AA i effektive mengder. It is of course possible to use the mixture as it is, or to incorporate the various components of the mixture separately from the fatty substance to be protected. In the case where, for example, the fatty substance is a vegetable oil that already naturally contains lecithin (LC), for example soybean oil, it is sufficient to add CoQ and AA in effective amounts.
I en fordelaktig utførelsesform av den foretrukne varianten beskrevet ovenfor, blir blandingen fremstilt ved kombinering av LC og CoQ med omrøring ved en temperatur under eller lik 60'C, fortrinnsvis mens en inert gass, for eksempel nitrogen, blir boblet igjennom. AA løst opp i et polart oppløsnings-middel, fortrinnsvis ved lavt kokepunkt, for eksempel etanol, blir deretter progressivt tilsatt til denne forblandingen, hvorpå oppløsningsmidlet blir frigjort ved en temperatur på 60"C, for eksempel i et lett vakuum. Den oppnådde blandingen er i form av en gjennomsiktig og viskøs væske. Den kan bli anvendt på forskjellige måter, for eksempel ved inkorporering i et fettstoff som skal bli beskyttet, fortrinnsvis med oppvarming, idet blandingen er ved omtrent 60 "C med omfattende røring. In an advantageous embodiment of the preferred variant described above, the mixture is prepared by combining LC and CoQ with stirring at a temperature below or equal to 60°C, preferably while an inert gas, for example nitrogen, is bubbled through. AA dissolved in a polar solvent, preferably at a low boiling point, for example ethanol, is then progressively added to this premix, after which the solvent is released at a temperature of 60°C, for example in a light vacuum. The resulting mixture is in the form of a transparent and viscous liquid. It can be used in various ways, for example by incorporation into a fatty substance to be protected, preferably with heating, the mixture being at about 60 "C with extensive stirring.
I en annen fordelaktig utførelsesform av den foretrukne varianten beskrevet ovenfor, blir AA og CoQ inkorporert i fettstoffet hvor lecitin på forhånd er blitt tilsatt, fortrinnsvis i form av en oppløsning i et polart oppløsnings-middel, for eksempel etylalkohol, hvorpå oppløsningsmidlet blir fjernet. In another advantageous embodiment of the preferred variant described above, AA and CoQ are incorporated into the fatty substance where lecithin has previously been added, preferably in the form of a solution in a polar solvent, for example ethyl alcohol, after which the solvent is removed.
Fettstoffene som skal bli beskyttet i henhold til oppfinnelsen er de som fortrinnsvis er mest følsomme for oksydasjon, for eksempel fettstoffer som er rike på umetning, spesielt polyumettede fettsyrer så som vegetabilske oljer, for eksempel hvetekimolje, druefrøolje, maisolje, soyabønne-olje, safrantistelolje, olivenolje, nattlysolje, agurkurte-olje og spesielt solbærfrøolje. Dyrefettstoffer mottagelig for oksydasjon omfatter kyllingfett, smørolje, oljer fra marine dyr, spesielt fiskeolje. The fatty substances to be protected according to the invention are those which are preferably most sensitive to oxidation, for example fatty substances which are rich in unsaturated fatty acids, especially polyunsaturated fatty acids such as vegetable oils, for example wheat germ oil, grape seed oil, corn oil, soybean oil, safflower oil, olive oil, evening primrose oil, borage oil and especially blackcurrant seed oil. Animal fats susceptible to oxidation include chicken fat, butter oil, oils from marine animals, especially fish oil.
Næringsmidlene, kosmetiske produkter eller farmasøytiske produkter som skal bli beskyttet, er fortrinnsvis de som inneholder slike fettstoffer. The foodstuffs, cosmetic products or pharmaceutical products to be protected are preferably those containing such fatty substances.
Oppfinnelsen er illustrert ved følgende eksempler der prosentandeler og deler er i vekt, dersom ikke annet er angitt. The invention is illustrated by the following examples where percentages and parts are by weight, unless otherwise stated.
EKSEMPEL 1 EXAMPLE 1
Fremstilling av prøver Preparation of samples
Prøver av 20 g olje stabilisert ved tilsetning av ubiquinon C0Q10(formel I, n = 10) i mengden angitt, blir fremstilt og blandet under omrøring, hvorpå prøvene blir plassert i lakkerte, steriliserte 200 ml tinnplatekanner i en mengde på 0,5 g stabilisert olje pr. baten pr. kanne. Kannene blir hermetisk forseglede og lagret ved 37°C. Samples of 20 g of oil stabilized by the addition of ubiquinone C0Q10 (formula I, n = 10) in the quantity indicated are prepared and mixed with stirring, after which the samples are placed in varnished, sterilized 200 ml tinplate jugs in an amount of 0.5 g stabilized oil per the benefit per jug. The jugs are hermetically sealed and stored at 37°C.
Aksellerert oksydas. lonstest Accelerated oxidase. loan test
Toppområdet av kannene inneholdende prøvene, blir annalysert innen en viss tid (i dager) ved bestemming av innholdet av pentan og etan som de respektive graderingsproduktene av linol og a-linoleumsyre ved oksydasjon og også gjenværende oksygeninnhold. For sammenligning blir de samme analysene utført med prøver fremstilt uten antioksyderingsmidler. Pentan- og etaninnholdet blir bestemt ved gassfasekromato-grafi mens oksygeninnholdet blir bestemt ved måling av den paramagnetiske mottageligheten. The top area of the cans containing the samples is analyzed within a certain time (in days) by determining the content of pentane and ethane as the respective graduation products of linoleic and α-linoleic acid by oxidation and also residual oxygen content. For comparison, the same analyzes are performed with samples prepared without antioxidants. The pentane and ethane content is determined by gas phase chromatography, while the oxygen content is determined by measuring the paramagnetic susceptibility.
Resultatene til denne testen er angitt i tabellene 1 og 2 nedenfor. The results of this test are set out in Tables 1 and 2 below.
Resultatene ovenfor demonstrerer klart antioksiderings-middelaktlviteten til CoO^q i fiskeolje og solbærfrøolje ved sammenligning med samme oljer uten CoQ^o- The above results clearly demonstrate the antioxidant activity of CoO^q in fish oil and blackcurrant seed oil when compared with the same oils without CoQ^o-
EKSEMPEL 2 EXAMPLE 2
Fremgangsmåten beskrevet i eksempel 1 blir påny anvendt for å måle pentan, etan og oksygeninnholdet til toppområdet i 200 ml kanner inneholdende 0,5 g fiskeolje stabilisert med The procedure described in example 1 is used again to measure the pentane, ethane and oxygen content of the top area in 200 ml jugs containing 0.5 g of fish oil stabilized with
Pentan, etan og oksygeninnholdet til toppområdet til kannene inneholdende fiskeolje uten stabiliseringsmiddel (C^), med 1.000 ppm AA (C2) og til slutt med 1.000 ppm AA + 1% LC (C3) blir bestemt for sammenligning. The pentane, ethane and oxygen content of the top region of the cans containing fish oil without stabilizer (C^), with 1,000 ppm AA (C2) and finally with 1,000 ppm AA + 1% LC (C3) are determined for comparison.
Oppnådde resultater er vist i tabell 3 nedenfor. The results obtained are shown in table 3 below.
Resultatene ovenfor viser klart at kombinasjon av CoQ^q, ÅA og LC i mengdene som blir anvendt gir effektiv beskyttelse av fiskeolje mot oksydasjon, selv etter lagring i 41 dag, mens uten stabiliseringsmiddel (C^) oksideres fiskeoljen hurtig etter 12te dag. Anvendelse av AA alene (C2) eller sammenblandet med LC (C3) tilveiebringer ikke lenger beskyttelse av fiskeolje overfor oksidasjon fra 19de dag. The results above clearly show that the combination of CoQ^q, ÅA and LC in the amounts used provides effective protection of fish oil against oxidation, even after storage for 41 days, while without stabilizer (C^) the fish oil oxidizes quickly after the 12th day. Application of AA alone (C2) or mixed with LC (C3) no longer provides protection of fish oil against oxidation from the 19th day.
Claims (9)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH3891/89A CH680072A5 (en) | 1989-10-27 | 1989-10-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO904647D0 NO904647D0 (en) | 1990-10-26 |
NO904647L NO904647L (en) | 1991-04-29 |
NO301651B1 true NO301651B1 (en) | 1997-11-24 |
Family
ID=4265725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO904647A NO301651B1 (en) | 1989-10-27 | 1990-10-26 | Approach. for the protection of a fat, food, cosmetic or pharmaceutical product content. a fatty substance against oxidation, fat, cosmetic, animal fat and vegetable oil, and of coenzyme Q as an antioxidant |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0424679B1 (en) |
JP (1) | JP3081226B2 (en) |
AT (1) | ATE131696T1 (en) |
AU (1) | AU637828B2 (en) |
CA (1) | CA2027677A1 (en) |
CH (1) | CH680072A5 (en) |
DE (1) | DE69024321T2 (en) |
DK (1) | DK0424679T3 (en) |
ES (1) | ES2081888T3 (en) |
IE (1) | IE71936B1 (en) |
NO (1) | NO301651B1 (en) |
NZ (1) | NZ235548A (en) |
PT (1) | PT95677B (en) |
ZA (1) | ZA908049B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2074395B1 (en) * | 1993-02-25 | 1996-03-01 | Lifepharma Srl | PHARMACEUTICAL OR DIETETIC COMPOSITION OF HIGH ANTIOXIDANT ACTIVITY IN CARDIOVASCULAR AND / OR HEPATIC PATHOLOGIES. |
JP3106820B2 (en) * | 1993-12-08 | 2000-11-06 | アールティーエー・アソシエーツ有限会社 | Livestock and fish meat and their processed products freshness preservative and productivity improver |
EP0803201A3 (en) * | 1996-04-23 | 1998-10-28 | Cpc International Inc. | Dietetic foods and pharmaceutical preparations inhibiting blood coagulation |
DE10036799A1 (en) * | 2000-07-28 | 2002-02-07 | Beiersdorf Ag | New treatment for hair and scalp |
TW200302054A (en) * | 2002-01-18 | 2003-08-01 | Kaneka Corp | Ubiquinone-enriched foods |
TW200302055A (en) * | 2002-01-18 | 2003-08-01 | Kaneka Corp | Ubiquinol-enriched fat-containing foods |
US20060251637A1 (en) * | 2003-03-11 | 2006-11-09 | Toshinori Ikehara | Oil-in-water type emulsion containing coenzyme q10 and process for producting the same |
WO2005097091A1 (en) * | 2004-04-09 | 2005-10-20 | Kaneka Corporation | Composition comprising reduced-form coenzyme q10 and carotenoid compound |
DE102014007762A1 (en) | 2013-05-31 | 2014-12-04 | Gabriele Pütz | Carbohydrate concentrate, process for its preparation and aqueous beverage concentrate |
DE202013004949U1 (en) | 2013-05-31 | 2013-07-08 | Gabriele Pütz | Carbohydrate concentrate |
EP3695729A1 (en) | 2019-02-14 | 2020-08-19 | Vandemoortele Lipids NV | Stabilized pufa containing fat compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2333656A (en) * | 1942-03-31 | 1943-11-09 | Lever Brothers Ltd | Antioxidant for fats and oils |
IT1191608B (en) * | 1985-02-01 | 1988-03-23 | Zambon Spa | PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL FORMS THAT CONTAIN IT |
IL78611A0 (en) * | 1986-04-23 | 1986-08-31 | Yeda Res & Dev | Production of polyprenoid and ubiquinone-type compounds |
AU606637B2 (en) * | 1986-11-05 | 1991-02-14 | George Weston Foods Limited | Novel improvers for flour and yeast raised baked goods |
-
1989
- 1989-10-27 CH CH3891/89A patent/CH680072A5/fr not_active IP Right Cessation
-
1990
- 1990-09-27 ES ES90118535T patent/ES2081888T3/en not_active Expired - Lifetime
- 1990-09-27 AT AT90118535T patent/ATE131696T1/en active
- 1990-09-27 EP EP90118535A patent/EP0424679B1/en not_active Expired - Lifetime
- 1990-09-27 DE DE69024321T patent/DE69024321T2/en not_active Expired - Fee Related
- 1990-09-27 DK DK90118535.5T patent/DK0424679T3/en active
- 1990-09-28 IE IE348690A patent/IE71936B1/en not_active IP Right Cessation
- 1990-10-03 NZ NZ235548A patent/NZ235548A/en unknown
- 1990-10-03 AU AU63745/90A patent/AU637828B2/en not_active Ceased
- 1990-10-08 ZA ZA908049A patent/ZA908049B/en unknown
- 1990-10-15 CA CA002027677A patent/CA2027677A1/en not_active Abandoned
- 1990-10-25 PT PT95677A patent/PT95677B/en active IP Right Grant
- 1990-10-26 JP JP02290629A patent/JP3081226B2/en not_active Expired - Fee Related
- 1990-10-26 NO NO904647A patent/NO301651B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO904647D0 (en) | 1990-10-26 |
IE71936B1 (en) | 1997-03-12 |
EP0424679A2 (en) | 1991-05-02 |
AU637828B2 (en) | 1993-06-10 |
DK0424679T3 (en) | 1996-03-25 |
PT95677B (en) | 1997-09-30 |
DE69024321T2 (en) | 1996-05-15 |
DE69024321D1 (en) | 1996-02-01 |
ZA908049B (en) | 1991-08-28 |
NO904647L (en) | 1991-04-29 |
JPH03167293A (en) | 1991-07-19 |
EP0424679A3 (en) | 1992-04-29 |
IE903486A1 (en) | 1991-05-08 |
AU6374590A (en) | 1991-05-02 |
ATE131696T1 (en) | 1996-01-15 |
JP3081226B2 (en) | 2000-08-28 |
PT95677A (en) | 1991-09-13 |
NZ235548A (en) | 1992-07-28 |
CH680072A5 (en) | 1992-06-15 |
ES2081888T3 (en) | 1996-03-16 |
CA2027677A1 (en) | 1991-04-28 |
EP0424679B1 (en) | 1995-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5258179A (en) | Protection of a food, cosmetic or pharmaceutical product against oxidation | |
DK173318B1 (en) | Synergic antioxidant blend | |
CA2068028C (en) | Liposoluble antioxidant mixture | |
US5527552A (en) | Lipid-soluble green tea catechin antioxidant solutions | |
Gonzalez et al. | Lipid peroxidation products are elevated in fish oil diets even in the presence of added antioxidants | |
US5871757A (en) | Stabilization of polyunsaturates | |
NO301651B1 (en) | Approach. for the protection of a fat, food, cosmetic or pharmaceutical product content. a fatty substance against oxidation, fat, cosmetic, animal fat and vegetable oil, and of coenzyme Q as an antioxidant | |
JPH11514221A (en) | New process | |
Papas | Oil-soluble antioxidants in foods | |
US5338838A (en) | Antioxidation active substance and utilization thereof | |
Meltzer et al. | Supplementary selenium influences the response to fatty acid-induced oxidative stress in humans | |
Levander et al. | Plasmodium yoelii: comparative antimalarial activities of dietary fish oils and fish oil concentrates in vitamin E-deficient mice | |
US5166375A (en) | Antioxidant and an oxidation resistant polyunsaturated oil | |
JPH09110888A (en) | Phospholipid composition | |
US5346890A (en) | Antioxidation active substance and utilization thereof | |
JPH1077225A (en) | Optically transparent aqueous-alcoholic solution of multivitamin containing beta-carotene | |
CN112888321A (en) | Oral composition containing reduced coenzyme Q10, method for producing same, method for inhibiting discoloration, and discoloration inhibitor | |
SU1004460A1 (en) | Antioxidant for stabilizing fats, oils and fat-like substances | |
EP0513354A1 (en) | Antioxidizing composition and composition containing the same | |
JPS635036A (en) | Squalene-containing composition | |
JPS6312117B2 (en) | ||
US3579357A (en) | Foodstuffs containing an antioxidant | |
Kumari et al. | Estimation of vitamin A and C content | |
Ellenberger | A STUDY OF THE VITAMIN A CONTENT OF VITAMIN A STANDARDS AND OF REPRESENTATIVE FISH OILS BY SPECTORPHOTOMETRIC AND BIOLOGICAL METHODS OF ASSAY AND A CALCULATION OF THEIR RESPECTIVE CONVERSION FACTORS | |
Oser et al. | Physiological availability to the rat of crude carotene in vegetables |